EUVIMEDEUVIMED entdecken
Crossref

Obstructive sleep apnea, positive airway pressure therapy, and COVID-19 outcomes

Matthew Klimper, Jiaxiao Shi, Adam V Benjafield, Kate V Cole, Aiyu Chen, Joanie Chung, Jessica Arguelles, Nathanael H Hwang, Kendra A Becker, Joseph B Kim, Rosa R Woodrum, Cecilia Portugal und 3 weitere

Sleep and Breathing · 2026-05 · 30 (2)

DOI: 10.1007/s11325-026-03675-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sleep and Breathing, online erschienen am 24.04.2026. Verfasst von Matthew Klimper und 14 weiteren Autor:innen. Beteiligte Einrichtung: Sleep Medicine, Kaiser Permanente Southern California, Southern California, USA. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, COVID-19, Continuous Positive Airway Pressure. Die Arbeit nennt 31 Literaturangaben. Gefördert von: American Academy of Sleep Medicine Foundation, Kaiser Permanente Division of Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To quantify the association between obstructive sleep apnea (OSA) and COVID-19 outcomes and test whether adherence to positive airway pressure (PAP) therapy modifies this relationship. METHODS: This retrospective cohort study compared groups with and without OSA, stratified by degrees of PAP adherence (February 1, 2020 to July 31, 2020) from an integrated healthcare system (Kaiser Permanente Southern California). Rates of COVID-19 infection and hospitalization were compared. Multivariable logistic regression estimated adjusted associations, controlling for demographic and clinical factors. RESULTS: Among 78,317 patients analyzed, a pattern revealed increased COVID-19 infection rate in those with OSA and decreased with PAP therapy: No OSA 1.9%; Untreated OSA (PAP use < 2 h/night) 2.2%; Moderately-treated OSA (PAP use 2–3.9 h/night) 1.9%; Well-treated OSA (PAP use ≥ 4 h/night) 1.4% (P < 0.0001). In adjusted models (reference: untreated OSA), odds of infection were lower for patients without OSA (aOR 0.83, 95% CI 0.71–0.97), similar with moderately-treated (2.0–3.9 h/night; aOR 0.88, 95% CI 0.70–1.12), and lower with well-treated OSA (≥ 4 h/night; aOR 0.71, 95% CI 0.62–0.82). Compared with White patients, Black and Hispanic patients had higher odds of infection (aORs 1.46 [1.21–1.77] and 2.14 [1.89–2.43]) and hospitalization (2.02 [1.22–3.35] and 1.66 [1.12–2.46]), highlighting disparities. Neither OSA nor PAP use appeared to influence COVID-19 hospitalization rates, although overall incidences were small. CONCLUSIONS: OSA was associated with higher risk of COVID-19 infection, whereas greater PAP adherence was associated with lower risk, suggesting potential pathogenic effects of untreated OSA and protective effects of PAP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Apnea, ObstructiveCOVID-19Continuous Positive Airway PressureHumansFemaleRetrospective StudiesMiddle AgedMaleHospitalizationPatient ComplianceAdultCaliforniaPandemicsSARS-CoV-2ComorbidityAged

Stichwörter der Autor:innen

COVID-19Continuous positive airway pressureEpidemiologyHealthcare disparitiesSleep apnea, obstructive

Autor:innen und Institutionen

  • Sleep Medicine, Kaiser Permanente Southern California, Southern California, USA.
  • Department of Research and Evaluation, Kaiser Permanente Southern California, Southern California, USA.
  • ResMed Science Center, ResMed Corp, San Diego, USA.
  • Scaled Insights, London, England.
  • Sleep Medicine, Kaiser Permanente Southern California, Southern California, USA. Dennis.X.Hwang@kp.org.

Förderung

  • American Academy of Sleep Medicine Foundation
  • Kaiser Permanente Division of Research

Zitieren

APA

Klimper, M., Shi, J., Benjafield, A. V., Cole, K. V., Chen, A., Chung, J., Arguelles, J., Hwang, N. H., Becker, K. A., Kim, J. B., Woodrum, R. R., Portugal, C., Hwang, O. H., Manthena, P., & Hwang, D. (2026). Obstructive sleep apnea, positive airway pressure therapy, and COVID-19 outcomes. Sleep and Breathing, 30(2). https://doi.org/10.1007/s11325-026-03675-2

Vancouver

Klimper M, Shi J, Benjafield AV, Cole KV, Chen A, Chung J, et al. Obstructive sleep apnea, positive airway pressure therapy, and COVID-19 outcomes. Sleep and Breathing. 2026;30(2). doi:10.1007/s11325-026-03675-2

BibTeX
@article{Klimper2026,
  author = {Klimper, Matthew and Shi, Jiaxiao and Benjafield, Adam V and Cole, Kate V and Chen, Aiyu and Chung, Joanie and Arguelles, Jessica and Hwang, Nathanael H and Becker, Kendra A and Kim, Joseph B and Woodrum, Rosa R and Portugal, Cecilia and Hwang, Olivia H and Manthena, Prasanth and Hwang, Dennis},
  title = {Obstructive sleep apnea, positive airway pressure therapy, and COVID-19 outcomes},
  journal = {Sleep and Breathing},
  year = {2026},
  volume = {30},
  number = {2},
  doi = {10.1007/s11325-026-03675-2}
}
Kostenlos starten →